Journals

I subscribe to a number of journals.

New England Journal of Medicine

From Crime to Care — On the Front Lines of Decarceration
New England Journal of Medicine, Volume 385, Issue 5, Page 385-387, July 2021.
>> Read more

Health Care Budgets for Rural Providers — Opportunities for Payment Reform
New England Journal of Medicine, Volume 385, Issue 5, Page 387-389, July 2021.
>> Read more

Identifying and Tracking SARS-CoV-2 Variants — A Challenge and an Opportunity
New England Journal of Medicine, Volume 385, Issue 5, Page 389-391, July 2021.
>> Read more

A Child’s Loss
New England Journal of Medicine, Volume 385, Issue 5, Page 391-393, July 2021.
>> Read more

Heart

Heartbeat: improved quality of life and reduced healthcare utilisation after catheter ablation in patients with drug-resistant paroxysmal atrial fibrillation
The role of catheter ablation of atrial fibrillation (AF) in management of patients with paroxysmal AF is controversial. In this issue of Heart, Gupta and colleagues1 report data from a multicentre study of 329 consecutive patients with drug-refractory paroxysmal AF treated with AF ablation by pulmonary vein isolation guided by a standardised CLOSE (contiguous optimised lesions) protocol. Patient reported quality of life (QOL) measures showed significant improvement across all domains at 12 months. In addition, QOL improvement was associated with a lower AF burden, measured by ambulatory monitoring. Overall, cardiovascular hospitalisations decreased by 42% after AF ablation. Patients with the lowest QOL measures at baseline had the most improvement after AF ablation (figure 1). Figure 1 Atrial fibrillation effect on quality of life survey (AFEQT) change versus baseline score. In the accompanying editorial, Elvan2 comments: ‘Significant reduction...
>> Read more

Its all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation
Atrial fibrillation (AF) is the most frequently encountered sustained cardiac arrhythmia that is associated with reduced quality of life (QOL) and increased risks of heart failure, cognitive impairment, stroke and death. Contemporary management of AF should primarily include optimal rhythm control strategy and stroke prevention in order to improve AF-related health outcome measures and patient satisfaction. In addition, modification of risk factors is important to consolidate treatment effects. Rate control with medication or ‘ablate and pace’ strategy should be reserved for patients with symptomatic AF in whom rhythm control is not a viable option.1 The major impact of AF on cardiovascular morbidity and mortality has driven the cardiac electrophysiology community to improve strategies to deliver therapies that are safe, effective and patient centred to timely restore and maintain sinus rhythm. Currently, the therapeutic armamentarium for rhythm control in patients with symptomatic AF includes anti-arrhythmic medication and catheter...
>> Read more

JACC

Heart Rhythm